vimarsana.com

பாரத் பயோடெக் இந்தியா லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Phase-3 Trials Show Covaxin 93 4 Per Cent Effective Against Severe COVID-19 But Supply Marred By Delay In Manufacturing

Phase-3 Trials Show Covaxin 93 4 Per Cent Effective Against Severe COVID-19 But Supply Marred By Delay In Manufacturing
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.

Vaccine Data Shows Centre Distributed 6 95 Crore More Doses Than It Got: RTI Activist

Vaccine Data Shows Centre Distributed 6.95 Crore More Doses Than It Got: RTI Activist Lokesh Batra has asked on the basis of the Centre s replies to his RTI queries how the number of vaccine doses distributed or supplied was 23.18 crore when only 16.23 crore had been procured till May 2. A syringe and a vial labelled COVID-19 vaccine are seen in front of the Indian flag. Photo: Reuters/Dado Ruvic Rights12 hours ago New Delhi: The Centre’s responses to RTI requests have led an activist to allege a difference of 6.95 crore doses between vaccines distributed and those received by the Centre, pointing to an inescapable and large discrepancy.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.